Herr Investment Group’s Anebulo Pharmaceuticals ANEB Stock Holding History

Herr Investment Group’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,644	Closed	-$71.8K	–	58
2022 Q4	$71.8K	Buy	+29,644	New	+$78.1K	﹤0.01%	82

Other funds holding ANEB

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Herr Investment Group's ANEB Position: Q1 2023 in Review

Herr Investment Group sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2023, closing a stake of 29,644 shares — an estimated $71.8K sold.

Herr Investment Group first reported a position in ANEB in Q4 2022 and held it in 1 quarter. The position peaked at $71.8K in Q4 2022. 10 funds tracked by Wall St. Rank hold ANEB as of Q1 2023.

Herr Investment Group reported no remaining Anebulo Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Herr Investment Group sold 29,644 Anebulo Pharmaceuticals shares in Q1 2023, an estimated $71.8K.
Herr Investment Group first reported a position in Anebulo Pharmaceuticals in Q4 2022 and held it in 1 quarter.
Herr Investment Group's Anebulo Pharmaceuticals position peaked at $71.8K in Q4 2022.
10 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2023.

Based on Herr Investment Group's 13F filing for Q1 2023, filed 10 May 2023.